In an interview with Money Life Podcast, IPOX® CEO Josef Schuster describes the IPO market as bullish and strong, driven by the performance of recent offerings. He notes that SPACs have returned and are a permanent fixture for companies going public. Schuster also highlights an innovative IPOX high-dividend strategy, which capitalizes on mispriced, income-generating companies. He suggests post-IPO investing can be a more liquid and cost-effective alternative to private equity.

Crypto exchange Bullish, backed by Peter Thiel, has upsized its IPO to target a $4.82B valuation. IPOX®’s Kat Liu says the pricing reflects trends of setting ranges below prior valuations, and stablecoin deployment will help accelerate infrastructure growth.

Reuters reports the Trump administration may launch IPOs for Fannie Mae and Freddie Mac this year, potentially valuing them at $500 billion. IPOX® VP Kat Liu cautions that a partial sale without a clear government exit plan could weigh on valuations, as investors may expect future sell-downs.

In a CNBC feature on the renewed momentum in space-related IPOs, IPOX® Research Associate Lukas Muehlbauer provided expert commentary on current market dynamics. He noted it is “definitely a good time for Space IPOs,” explaining that while government contracts provide insulation from tariffs, dependency on foreign components remains a vulnerability. Muehlbauer also highlighted how increased competition will lower entry barriers for new business models.

In a Reuters article covering Heartflow's upsized U.S. initial public offering, IPOX® Research Associate Lukas Muehlbauer provided expert analysis on the rebounding medtech IPO market. He noted that Heartflow's success "stands out, with the tightened price range indicating a well-covered book and strong demand," signaling positive momentum for the sector after a multi-year downturn.